Skip to search boxSkip to navigationSkip to main content

Capsaicin Nanoparticles as Therapeutic Agents against Gliomas

  • Evelin Martínez-Benavidez
    ,
  • ,
  • Sara Elisa Herrera-Rodríguez
    ,
  • Ofelia Yadira Lugo-Melchor(corresponding author)
    ,
  • Francisco Martín Goycoolea
    ,
  • Francisco Javier Guerrero Jazo
*Corresponding author for this work
Research Output:
Contribution to journal
Review article
Peer-review

Open access

Publication Information

Output type

Research Output:
Contribution to journal
Review article
Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 433-445 (13 pages)

Journal (Volume, Issue Number)

Nano Biomedicine and Engineering (Volume 13, Issue 4)

Publication milestones

  • Published - 01/01/2021

Publication status

Published - 01/01/2021

Publication IDs

  • Scopus: 85123453698

Abstract

Capsaicin is an alkaloid molecule with outstanding biological activity. Several reports have shown that capsaicin exerts significant antitumoral effects in several cancer cell lines, including gliomas. However, its application has been very limited due to its hydrophobicity, low affinity, and short life span. Gliomas are a heterogeneous group of brain malignant tumors with increasing prevalence worldwide. Standard therapy against these tumors generally includes resection by surgery, radiation, and chemotherapy or their combination. However, elicitation of tumor resistance to chemical or radiation treatments remains one of the main challenges to be resolved, particularly in the case of glioblastomas. Nanotechnology is an innovative approach to the treatment of Central Nervous System diseases and especially to gliomas treatment. Indeed, the use of nanotherapeutic formulations offers several advantages over the conventional methods of drug delivery therapy. In this review, we analyzed the current literature regarding the development of capsaicin-loaded nanoparticles as a promising approach for the treatment of malignant brain tumors.